SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is actively trending as the crypto community enthusiastically discusses multiple bullish technical indicators, including potential golden crosses and significant chart breakouts. Many investors are anticipating a substantial repricing event for the asset, driven by its established 'digital silver' narrative and perceived undervaluation, with sentiment pointing towards a major rally.

🔥 COCK Token – The Ultimate Cross-Chain MemeFi Powerhouse 🔥  In just under 20 days, $COCK has smashed expectations, broken ATHs, and built a project that’s shaking up Cardano and the entire crypto space. 🐓 What Makes $COCK Special?      The Name: Love it or hate it, the energy and engagement it generates are undeniable. The nuance in language and wild appeal set us apart.     #MEMEFI Pioneer: We’re not just another meme coin. $COCK is leading a movement by combining DeFi mechanics, game theory, and community engagement into a groundbreaking ecosystem.     COCKARENA: At the core of our ecosystem is the COCKARENA, a PvP HODL game. Players battle it out, and early exit fees fuel redistributions, burns, and the treasury. This ensures price appreciation and long-term sustainability for loyal holders.  🎰 The COCK Casino  Our casino isn’t just fun—it’s a serious revenue stream for the FLOCK.      Games: Bonanza, Crash, Blackjack, and Roulette (coming soon!).     Impact: Over 7,834 ADA in profits generated within days, directly supporting rewards, burns, and reinvestment.  💰 COCK-ARENA Loans  Unlock liquidity without selling your tokens.      Loan Terms: Borrow up to 30% of your holdings while continuing to earn rewards in the arena.     Investor Focus: Perfect for savvy investors staying in the game while tapping into their holdings.  🤝 Our Insane Partnerships  We’re bridging gaps, building alliances, and breaking barriers across the crypto space. Key Partners:      DANZO: Powering #MEMEFI with Arena, Casino, and Loans.     KLENEK: Interactive training room.     HSKN (Charles Hoskilien): Supporting and starting COCKPIN with 115 AIR NODES for DePIN aggregation. Plans to add APEX and Earth Nodes through a crypto company incorporated in Costa Rica.     ELITE CATS / SNEKKIES / HOT / BANK: Rewarding NFT holders with COCK-LOCK tokens and vice versa.     OCKZ: COCKSOCKS, Golden Cock Ticket (1M COCK), airdrop rewards, and whitelist perks for holders of 200 ADA worth of $COCK.     OLI Partnership:         Content Creation: Lux and the team are crafting engaging educational content about memes and MemeFi for OLi's platform.         Strategic Investment: The OLi Community Trust will invest in $COCK, distributing 100% of rewards to $OLI holders.         Community Reach: Over 22,000 learners will discover $COCK through OLi's gamified ecosystem.     Hi-Rez the Rapper: Expanding reach in marketing and entertainment.     KUNO, CALEB, CADEN, FITY, ROVER, WhaleInsider: Influential collaborators driving crypto adoption and growth.     Cardano Girls: Helping us understand and communicate effectively with ADA’s female audience.     WallStreetBets: Breaking barriers and increasing engagement.     Antonio Brown: Endorsing, supporting, and even playing in the casino and arena!     Advisors:         BERIS, HECKTHESNEK, RTB, CRYPTOGENIUS: Trusted names advising and supporting the project.  Future Partnerships:  More collaborations are in the pipeline to continue expanding engagement and bring new eyes to ADA and CNTs. 🔥 Unmatched Results in Just 20 Days      Supply Burned: 1.65%, worth 148K ADA!     Arena Fees Collected: 54M COCK, worth over 500K ADA, fueling rewards, burns, and partnerships.     Staked COCK-LOCK: 11M COCK-LOCK in the liquid staking platform, with more coming.     Casino Revenue: Skyrocketing profits directly rewarding holders and growing the treasury.     Top Blast Contests: Generated over 120K ADA in volume, rewarding participants with over 50K ADA in prizes.  🌍 Our Vision  To be the most decentralized, rewarding, and innovative token on Cardano while fostering cross-chain collaboration and onboarding the masses.      Breaking Barriers: We’re bringing BTC, ETH, SOL, and other chains into the fold.     Community-Driven: Focused on building bridges and showcasing that crypto can be fun, rewarding, and sustainable.     Expansion: This is just the beginning. With more burns, rewards, and partnerships on the way, $COCK is set to redefine what’s possible in the MemeFi space.  💎 Time in the arena > Timing the market. The FLOCK is unstoppable. Let’s keep breaking walls for Cardano and onboard new users as we take $COCK to new heights.

CockCardano

COCK CRYPTO is generating significant buzz following the recent launch of its MemesHub DApp, which integrates gamified finance and meme tracking for Cardano native tokens. The community is actively discussing the project's unique blend of real-world utility through its Cocky Wings LLC food truck and passive earning opportunities in the Arena. This innovative approach, emphasizing 'real builders' and tangible revenue streams within the Cardano ecosystem, is fueling strong bullish sentiment and consistent trending status.

Optex Systems Holdings, Inc. engages in the business of manufacturing optical sighting systems and assemblies for the Department of Defense, foreign military applications, and commercial markets. It operates through the following segments: Optex Systems Richardson and Applied Optics Center Dallas. The Optex Systems Richardson segment handles optical sighting systems and assemblies' production. The Applied Optics Center Dallas segment serves as the key supplier of laser coated filters used in the production of periscope assemblies. The company was founded in 1987 and is headquartered in Richardson, TX.

Optex Systems Holdings Inc

Optex Systems is trending as a defense sector player showcasing strong financial results, including significant revenue and earnings growth driven by increasing military contract demand. The community views it as a profitable, undervalued micro-cap with a substantial and expanding backlog, sparking optimism for its future performance.

Snek is a cultural movement and leading currency for meme creators worldwide.

SNEK

SNEK is generating significant buzz through its innovative partnership with Cocky Wings LLC, integrating "Snek Energy" drinks into real-world asset ventures within the Cardano ecosystem. The community is actively discussing SNEK's recent listings on major exchanges and its established utility as a liquidity bridge for Cardano assets, reinforcing its position as a dominant native token poised for further growth and mainstream adoption.

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible (RARI) is trending after its integration with Aleph Zero, which aims to enhance NFT minting and trading with faster, lower-cost transactions on its platform. The community remains sharply divided, with many expressing deep frustration over past price performance while a bullish contingent highlights its low market cap and limited supply, anticipating a significant surge with a potential NFT market rebound or new exchange listings.

SILVER is a crypto project that links traditional silver with digital assets. Each unit of SILVER is backed by an equal amount of $SILVER tokens, ensuring stable value and easy trading in a secure blockchain environment. With SILVER, users can convert real silver into digital assets and trade globally with low fees. Each $SILVER token is backed by actual silver, offering stability and reliability for investors to grow their wealth. SILVER is a crypto project that links traditional silver with digital assets. Each unit of SILVER is backed by an equal amount of $SILVER tokens, ensuring stable value and easy trading in a secure blockchain environment. With SILVER, users can convert real silver into digital assets and trade globally with low fees. Each $SILVER token is backed by actual silver, offering stability and reliability for investors to grow their wealth.

SILVER

Silver is experiencing an intense surge, fueled by escalating safe-haven demand amidst global economic concerns, strong central bank buying, and tightening supply conditions. The community is actively discussing a potential 'silver squeeze' and anticipating significant price movements. Many are dismissing bearish sentiments while others caution about a possible bubble or a sharp reversal.

Domo, Inc. designs, develops, and markets executive management software solutions. It offers customized software tools for business operations, customer relationship management, human resources, and financial reporting. The company was founded by Joshua G. James in September 2010 and is headquartered in American Fork, UT.

Domo Inc. - Ordinary Shares - Class B

Domo Inc.

Domo is trending amidst a significant stock drop despite recently reporting an earnings beat on both non-GAAP EPS and revenue, a performance that also showcased continued adjusted profitability and a path towards being free cash flow positive for the fiscal year. The community is actively debating whether the sharp sell-off is an overreaction driven by future guidance or unmet expectations, while some see potential for a strategic buyout given its competitive position in the data and AI sector.

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

Sanofi - ADR

Sanofi-Aventis

Sanofi is trending as it strategically expands its adult immunization footprint through a recent acquisition, while simultaneously navigating pipeline challenges following regulatory setbacks and a trial miss for an MS drug. Despite these mixed developments, community discussions persist around Sanofi's active role as an acquirer in the biotech sector, with several smaller companies frequently named as potential targets in areas like metabolic diseases.

Global X Funds - Global X Silver Miners ETF

The Global X Silver Miners ETF (SIL) is trending as silver experiences a parabolic surge to all-time highs, fueled by significant supply deficits and booming industrial demand across key sectors. Despite some community frustration that miners are currently lagging the metal's spot price, investors anticipate a substantial 'catch-up' rally, with widespread speculation of triple-digit silver prices and a rebalance of the gold-to-silver ratio.

Midnight is a privacy-first blockchain that blends public verifiability with confidential data handling. You can use Midnight's selective disclosure and ZK proofs to build apps.

Midnight

Midnight Protocol ($NIGHT) is experiencing significant market attention and a price surge, fueled by massive trading volume, recent major exchange listings, and the ongoing "Glacier Drop" airdrop. The crypto community is actively discussing its potential as a leading privacy-focused blockchain within the Cardano ecosystem, designed for institutional adoption with ZK technology and developer-friendly tools.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Cantor Fitzgerald’s new price target on CABA represents over 1,000% potential upside to the stock’s closing price on Thursday.</li><li>The company said on Monday that data from across trials reinforce the potential of a single weight-based dose of Rese-cel to deliver durable, drug-free clinical responses across multiple autoimmune diseases.</li><li>Rese-cel is an investigational, autologous CAR-T cell therapy explicitly designed for the treatment of autoimmune diseases in rheumatology, neurology, and dermatology. &nbsp;</li></ul>Cantor Fitzgerald on Friday raised its price target on Cabaletta Bio (CABA) to $30 from $15 while keeping an ‘Overweight’ rating on the shares.The new price target represents over 1,000% potential upside to the stock’s closing price on Thursday.According to TheFly, the analyst noted that Auto-CAR-T is showing unprecedented and transformational efficacy in systemic sclerosis, and investors aren't appreciating the substantial unmet need.Scleroderma, also known as systemic sclerosis, is a group of autoimmune diseases that cause the hardening and tightening of the skin and connective tissues, and can also damage blood vessels and internal organs. It is characterized by the excessive buildup of collagen, which leads to fibrosis.<h2 class="st-heading-2">Cabaletta Presents Positive Data</h2>Cabaletta on Monday announced positive clinical data across trials evaluating Rese-cel. Rese-cel is an investigational, autologous CAR-T cell therapy explicitly designed for the treatment of autoimmune diseases in rheumatology, neurology, and dermatology. It is administered as a single, weight-based infusion to reset the immune system and achieve durable clinical responses without the need for chronic therapy.The company said that the data from the trials reinforce the potential of a single weight-based dose of Rese-cel to deliver durable, drug-free clinical responses across multiple autoimmune diseases.“We look forward to initiating the myositis registrational trial and anticipate alignment with FDA on the designs for lupus and systemic sclerosis this year,” said David J. Chang, Chief Medical Officer of Cabaletta, on Monday.While Myositis is a group of rare conditions characterized by muscle inflammation, Lupus is a chronic autoimmune disease where the body's immune system mistakenly attacks healthy tissues.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/CABA">CABA stock</a> stayed within the ‘neutral’ territory over the past 24 hours, while message volume fell from ‘high’ to ‘normal’ levels.<figure class="image"><img style="aspect-ratio:621/60;" src="data:image/png;base64,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" width="621" height="60" alt="CABA's Sentiment Meter and Message Volume as of 12:19 p.m. ET on Oct. 31, 2025 | Source: Stocktwits"><figcaption>CABA's Sentiment Meter and Message Volume as of 12:19 p.m. ET on Oct. 31, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user expects the company’s pipeline to generate substantial revenue in six years.<stembedurl>https://stocktwits.com/Bronco6970/message/634482351</stembedurl>CABA stock is up by 46% this year but has dropped 7% over the past 12 months. &nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/pony-ai-stock-flips-between-gains-and-losses-after-key-shenzhen-permit/cLGqPQKR3U6">Pony AI Stock Flips Between Gains And Losses After Key Shenzhen Permit: Retail Expects Shares ‘Will Run Up In The Future’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Cabaletta Bio logo is seen displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

Why Does Cantor Fitzgerald See Over 1,000% Potential Upside For Cabaletta Bio Stock?

The analyst noted that Auto-CAR-T is showing unprecedented and transformational efficacy in systemic sclerosis, and investors aren't appreciating the substantial unmet need this represents. 

Equity

Small-Cap ETFs Rally in July: Will the Momentum Continue?

Small-cap ETFs like AVSC, XSVM, BBSC, SVAL and EES are soaring in July, fueled by rate cut hopes, deep discounts and sector rebounds.


Shares of Corvus Pharmaceuticals, Inc., fell in Tuesday's extended trading hours after the company posted financial results below Wall Street expectations, although retail traders remained optimistic.The pre-revenue biotech posted an adjusted fourth-quarter (Q4) loss of $0.18 per share, steeper than the expected $0.12 loss.&nbsp;Research and development expenses in the reported quarter rose to $6 million from $4 million a year earlier, primarily due to increased spending on the soquelitinib clinical trial for T-cell lymphoma.R&amp;D expenses climbed to $19.4 million for the full year from $16.5 million in 2023."We continue to advance our selective ITK inhibitor, soquelitinib, in a range of diseases," said CEO Richard Miller.Preclinical data supports its potential in a range of conditions, including solid tumors, autoimmune disorders such as ALPS and systemic sclerosis, as well as inflammatory diseases like asthma and psoriasis.Corvus is nearing complete enrollment in the third cohort of its Phase 1 atopic dermatitis trial, while its Phase 3 trial in peripheral T-cell lymphoma (PTCL) is enrolling patients across multiple sites.&nbsp;The company recently launched a Phase 2 trial for ALPS and plans to initiate a solid tumor study in the third quarter of 2025.As of Dec. 31, 2024, Corvus held $52 million in cash, cash equivalents, and marketable securities, up from $27.1 million a year ago, which it expects to fund operations into the first quarter of 2026.On Stocktwits, sentiment for Corvus flipped into 'extremely bullish' territory from 'bearish' a day ago, accompanied by a 1,000% spike in message volume.<figure class="image"><img style="aspect-ratio:1318/302;" src="https://news.stocktwits-cdn.com/CRVS_sentiment_and_message_volume_as_of_March_25_png_2347150685.webp" alt="CRVS sentiment and message volume as of March 25.png" width="1318" height="302"><figcaption>CRVS sentiment and message volume as of March 25. | source: Stocktwits</figcaption></figure>One user was bullish after the company's chief executive said the full data for the first three cohorts of its atopic dermatitis trial would be presented at the Society for Investigative Dermatology (SID) Annual Meeting in San Diego in May.<stembedurl>https://stocktwits.com/WalterBean/message/609216709</stembedurl>Another retail watcher expects the stock to close above $4 on Wednesday.<stembedurl>https://stocktwits.com/tradingjunk321/message/609231445</stembedurl>Corvus stock is down more than 28% this year but has more than doubled over the past 12 months. According to Koyfin, out of the six analysts covering the stock on Wall Street, five rate it 'buy' and one rates it 'strong buy.'For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stockbroker analyzing financial stock market with reflection on eyeglasses. Photo via Westend61 on Getty Images

Corvus Pharma Stock Dips On Bigger-Than-Feared Q4 Loss, But Retail’s Faith Grows Stronger

Research and development expenses in the reported quarter rose by $2 million, primarily due to increased spending on the soquelitinib clinical trial for T-cell lymphoma. 

Verint Systems, Inc. ($VRNT), a customer experience automation company, announced fiscal year 2025 third-quarter results that exceeded expectations, thanks to strong artificial intelligence (AI) momentum. The company maintained its full-year guidance, sending its shares sharply higher on Thursday.The Melville, New York-based company reported third-quarter non-GAAP earnings per share (EPS) of $0.54, down from the $0.65 earned a year ago but exceeding the consensus estimate of $0.43.Revenue climbed 3% year-over-year to $224 million, above the average analysts’ estimate of $210.13 million. The revenue growth was 5% on a non-GAAP basis, as adjusted for the divestiture of the quality managed services business.Dan Bodner, Verint CEO, said, “We are pleased with our momentum in AI innovation and in customers reporting strong, tangible AI business outcomes with the Verint open platform.”“In Q3, we saw strong demand for AI business outcomes and our bundled SaaS revenue growth accelerated to 19% year-over-year.”Verint said its new software-as-a-service (SaaS) average contract value (ACV) bookings for new deals, excluding cloud conversions, increased 37% YoY in the third quarter.Gross margins expanded 70 basis points YoY due to the mix shift toward recurring revenue.The company maintained its 2025 revenue guidance of $933 million, +/- 2 percentage points and EPS outlook of $2.90. Analysts, on average, estimate the numbers to be $933.26 and $2.91, respectively.Verint also announced its latest AI-powered bot on the Veint platform on Thursday.&nbsp;CFO Grant Highlander said the company will showcase its AI differentiation at the upcoming investor day on January 14.&nbsp;“Investors will hear directly from our customers on AI business outcomes and we will review our financial model, including FYE26 guidance and our long-term model for monetizing AI,” he added.<figure class="image"><img style="aspect-ratio:643/137;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/vrnt_sentiment_8f1342b2c0.png" alt="vrnt-sentiment.png" width="643" height="137"><figcaption>VRNT sentiment and message volume December 5, 2024, premarket as of 11:26 am ET | Source:&nbsp;Stocktwits</figcaption></figure>Stocktwits users are ‘extremely bullish’ (97/100) toward the stock, with sentiment improving from neutral a day ago. Message volume continues to be ‘extremely high.’At last check, Verint shares climbed 24.53% to $32.34. The stock has lost about 4% this year but has traded in the $21-$38 range.For updates and corrections email newsroom[at]stocktwits[dot]com.

Artificial Intelligence - Chatbot concept in neon style - stock photo

Verint Stock Soars On AI-Fueled Q3 Beat: Retail Sentiment Brightens

Verint highlighted the momentum in AI innovation and customers reporting strong, tangible AI business outcomes with its open platform.

AVSC
American Century ETF Trust - Avantis U.S Small Cap Equity ETF

Feed

News

Sentiment

Fundamentals

Info

Latest AVSC News

AVSCAmerican Century ETF Trust - Avantis U.S Small Cap Equity ETF